| Completed | A Study of Orally Administered JNJ-440 to Evaluate the Safety, Tolerability, and Pharmacokinetics After Single Chronic Hepatitis B | Phase 1 | 2018-03-26 |
| Terminated | A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Dosing Regimens of AL-794 in Healt Healthy | Phase 1 | 2018-03-03 |
| Withdrawn | A Study Evaluating AL-3778 in Combination With Peginterferon Alpha-2a in Chronic Hepatitis B Subjects Hepatitis B, Chronic | Phase 2 | 2017-09-12 |
| Completed | A Study of AL-034 to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses in He Hepatitis B | Phase 1 | 2017-09-07 |
| Terminated | A First in Human Study of AL-611 in Healthy Volunteers and Patients With Hepatitis C Virus Infection Hepatitis C | Phase 1 | 2017-07-07 |
| Terminated | Study of the Relative Oral Bioavailability of AL-3778 Tablets and Drug Interaction With Entecavir or Tenofovir Hepatitis B, Chronic Hepatitis B, Viral Hepatitis B | Phase 1 | 2017-01-31 |
| Completed | A Drug-Drug Interaction Study to Evaluate the Effect of AL-794 on the Pharmacokinetics of Oseltamivir and JNJ- Influenza in Humans | Phase 1 | 2016-07-31 |
| Completed | A Study to Assess the PK of AL-794 Formulations in Healthy Subjects Influenza | Phase 1 | 2016-06-30 |
| Completed | A Phase 2a Study to Evaluate Orally Administered ALS-008176 in Adults Hospitalized With a Respiratory Syncytia Respiratory Syncytial Virus Infections | Phase 2 | 2016-02-29 |
| Completed | A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of the Combination of AL-335, Odalasvir, and Sim Chronic Hepatitis C | Phase 2 | 2015-10-31 |
| Completed | A Study of AL-794 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses, and Influenza | Phase 1 | 2015-08-31 |
| Terminated | First in Human Study of AL-704; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepa Chronic Hepatitits C | Phase 1 | 2015-07-31 |
| Completed | A Study to Evaluate the Effect of ACH-3102 and Simeprevir on AL-335 Pharmacokinetics in Healthy Volunteers Chronic Hepatitis C | Phase 1 | 2015-07-31 |
| Completed | First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepa Chronic Hepatitis C | Phase 1 | 2014-12-31 |
| Completed | A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-00817 Respiratory Syncytial Virus Infections | Phase 1 | 2014-08-31 |
| Completed | A Study of ALS-008176 in Infants Hospitalized With RSV Respiratory Syncytial Virus Infections | Phase 1 | 2014-07-23 |
| Completed | A Phase 2a Study to Evaluate ALS-008176 in the Virus Challenge Model Respiratory Syncytial Virus Infections | Phase 2 | 2014-03-01 |
| Completed | Study of Single and Multiple Doses of ALS-008176 in Healthy Volunteers Respiratory Syncytial Virus Infections | Phase 1 | 2013-05-31 |
| Completed | A Phase 2a, Dose-Ranging Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VX-135 With Ribavirin Chronic Hepatitis C | Phase 2 | 2013-02-28 |
| Completed | First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C, Chronic | Phase 1 | 2011-12-31 |
| Terminated | First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C, Chronic | Phase 1 | 2011-12-31 |